Drugs / 4B5
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00004184 | Aug 1998 → Jun 2001 | cutaneous melanoma | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4B5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004184 ↗ |
| Route | Subcutaneous | “4B5 plus alum SQ on days 0, 14, 28, and 42” NCT00004184 ↗ |